Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

Cited by (1,003)

Items 201–300 of 1,003

1. Quantitative Spatial Profiling of PD-1/PD-L1 Interaction and HLA-DR/IDO-1 Predicts Improved Outcomes of Anti–PD-1 Therapies in Metastatic Melanoma
   Douglas Buckner Johnson, Jennifer Bordeaux, Ju Young Kim, Christine Vaupel, David L. Rimm, Thai H. Ho, Richard Wayne Joseph, ADIL I. DAUD, Robert Martin Conry, Elizabeth Mary Gaughan et al. · 2018 · Clinical Cancer Research
2. Neutrophil Heterogeneity in Cancer: From Biology to Therapies
   Pacôme Lecot, Matthieu Sarabi, Manuela Pereira-Abrantes, Julie Mussard, Leo Koenderman, Christophe Caux, Nathalie Bendriss‐Vermare, Marie‐Cécile Michallet · 2019 · Frontiers in Immunology
3. Phase I Clinical Trial of Combination Propranolol and Pembrolizumab in Locally Advanced and Metastatic Melanoma: Safety, Tolerability, and Preliminary Evidence of Antitumor Activity
   Shipra Gandhi, Manu Raj Pandey, Kristopher M. Attwood, Wenyan Ji, Agnieszka Katarzyna Witkiewicz, Erik S. Knudsen, Cheryl L. Allen, Joseph Dennis Tario, Paul K. Wallace, Carlos D. Cedeno et al. · 2020 · Clinical Cancer Research
4. Immunosuppression in Glioblastoma: Current Understanding and Therapeutic Implications
   Benjamin T. Himes, Philipp A. Geiger, Katayoun Ayasoufi, Adip Guruprasad Bhargav, Desmond A. Brown, Ian F. Parney · 2021 · Frontiers in Oncology
5. Neutralization of IL-8 decreases tumor PMN-MDSCs and reduces mesenchymalization of claudin-low triple-negative breast cancer
   Charli L. Dominguez, Kristen K. McCampbell, Justin M. David, Claudia Palena · 2017 · JCI Insight
6. Low-density granulocytes activate T cells and demonstrate a non-suppressive role in systemic lupus erythematosus
   Saifur Rahman, Divya Sagar, Richard N. Hanna, Yaima Luzardo Lightfoot, Pragnesh Mistry, Carolyne K. Smith, Zerai G. Manna, Sarfaraz Hasni, Richard M. Siegel, Miguel A. F. Sanjuán et al. · 2019 · Annals of the Rheumatic Diseases
7. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non–Small Cell Lung Cancer
   Yoshikane Yamauchi, Seyer Safi, C Blattner, Anchana Rathinasamy, Ludmila Umansky, Simone Juenger, Arne Warth, Martin Eichhorn, Thomas Muley, Felix J.F. Herth et al. · 2018 · American Journal of Respiratory and Critical Care Medicine
8. Aging, inflammation and cancer
   Barbara Bottazzi, Elio Ríboli, Alberto Mantovani · 2018 · Seminars in Immunology
9. MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
   Livingstone Fultang, Silvia Panetti, Margaret H.L. Ng, Paul J. Collins, Suzanne Graef, Nagy Rizkalla, Sarah Booth, Richard Lenton, Boris Noyvert, Claire D Shannon-Lowe et al. · 2019 · EBioMedicine
10. Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
    Augusto Bleve, Francesca Motta, Barbara Durante, Chiara Pandolfo, Carlo Selmi, Antonio Sica · 2022 · Clinical Reviews in Allergy & Immunology
11. The Notch signaling pathway: a potential target for cancer immunotherapy
    Xinxin Li, Xianchun Yan, Yufeng Wang, Balveen Kaur, Hua Han, Jianhua Yu · 2023 · Journal of Hematology & Oncology
12. Neutrophils suppress tumor‐infiltrating T cells in colon cancer via matrix metalloproteinase‐mediated activation of TGFβ
    Markus Germann, Nadine Zangger, Marc‐Olivier Sauvain, Christine L Sempoux, Amber D. Bowler, Pratyaksha Wirapati, Lana Elias Kandalaft, Mauro Delorenzi, Sabine Tejpar, George Coukos et al. · 2019 · EMBO Molecular Medicine
13. TLR 7/8 agonist reverses oxaliplatin resistance in colorectal cancer via directing the myeloid-derived suppressor cells to tumoricidal M1-macrophages
    Zhipeng Liu, Yue Xie, Yao Xiong, Siliang Liu, Chen Qiu, Zhenhao Zhu, Hua Mao, Meng Yu, Xinying Wang · 2019 · Cancer Letters
14. Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigration
    Sheri A. C. McDowell, Robin B. Luo, Azadeh Arabzadeh, Samuel Doré, Nicolas C. Bennett, Valérie Breton, Elham Karimi, Morteza Rezanejad, Ryan R. Yang, Katherine D. Lach et al. · 2021 · Nature Cancer
15. Immune suppression in chronic hepatitis B infection associated liver disease: A review
    Tian-Yang Li, Yang Yang, Guo Feng Zhou, Zhengkun Tu · 2019 · World Journal of Gastroenterology
16. Long noncoding RNA Pvt1 regulates the immunosuppression activity of granulocytic myeloid-derived suppressor cells in tumor-bearing mice
    Yu Zheng, Xinyu Tian, Tingting Wang, Xueli Xia, Fenghua Cao, Jie Tian, Ping Xu, Jie Ma, Huaxi Xu, Shengjun Wang · 2019 · Molecular Cancer
17. Drug Resistance in Colorectal Cancer: From Mechanism to Clinic
    Wang, Qianyu, Shen, Xiaofei, Chen, Gang, Du, Junfeng · 2022 · Cancers
18. Myeloid cell heterogeneity in cancer: not a single cell alike
    Kiss, Mate, Van Gassen, Sofie, Movahedi, Kiavash, Saeys, Yvan, Laoui, Damya · 2018 · Cellular Immunology
19. The CD14+HLA-DRlo/neg Monocyte: An Immunosuppressive Phenotype That Restrains Responses to Cancer Immunotherapy
    April E. Mengos, Dennis A. Gastineau, Michael P. Gustafson · 2019 · Frontiers in Immunology
20. Glioblastoma Myeloid-Derived Suppressor Cell Subsets Express Differential Macrophage Migration Inhibitory Factor Receptor Profiles That Can Be Targeted to Reduce Immune Suppression
    Tyler Joseph Alban, Defne Bayık, Balint Otvos, Anja Rabljenovic, Lin Leng, Jia-Shiun Leu, Gustavo A. Roversi, Adam J. Lauko, Arbaz A. Momin, Alireza Mohammad Mohammadi et al. · 2020 · Frontiers in Immunology
21. Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer
    Sara A. Väyrynen, Jinming Zhang, Chen Yuan, Juha P. Väyrynen, Andressa Dias Costa, Hannah L. Williams, Vicente Morales‐Oyarvide, Mai Chan Lau, Douglas Adam Rubinson, Richard Francis Dunne et al. · 2020 · Clinical Cancer Research
22. Mechanisms of T-Cell Exhaustion in Pancreatic Cancer
    Didem Saka, Muazzez Gökalp, Betül Piyade, Nedim Can Çevik, Elif Arik Sever, Derya Unutmaz, Guralp Onur Ceyhan, İhsan Ekin Demir, Hande Asimgil · 2020 · Cancers
23. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma
    Carole Siret, Aurélie Collignon, Françoise Silvy, Stéphane Robert, Thierry Cheyrol, Perrine André, Véronique Rigot, Juan Iovanna, Serge A. van de Pavert, Dominique Lombardo et al. · 2020 · Frontiers in Immunology
24. N1 versus N2 and PMN‐MDSC: A critical appraisal of current concepts on tumor‐associated neutrophils and new directions for human oncology
    Benedict Boateng Antuamwine, Rebeka Bosnjakovic, Francisca Hofmann-Vega, Xi Wang, Θεοδόσιος Θεοδοσίου, Ioannis Iliopoulos, Sven Brandau · 2022 · Immunological Reviews
25. Interleukin-10 produced by myeloid-derived suppressor cells is critical for the induction of Tregs and attenuation of rheumatoid inflammation in mice
    Min-Jung Park, Sung‐Hee Lee, Eun‐Kyung Kim, Eunjung Lee, Jin-Ah Baek, Sung‐Hwan Park, Seung‐Ki Kwok, Mi‐La Cho · 2018 · Scientific Reports
26. Cancer exosome-derived miR-9 and miR-181a promote the development of early-stage MDSCs via interfering with SOCS3 and PIAS3 respectively in breast cancer
    Mengmeng Jiang, Wenwen Zhang, Rui Zhang, Pengpeng Liu, Yingnan Ye, Wenwen Yu, Xiaojing Guo, Jinpu Yu · 2020 · Oncogene
27. Metabolic programs define dysfunctional immune responses in severe COVID-19 patients
    Elizabeth A. Thompson, Katherine Cascino, Alvaro A. Ordoñez, Weiqiang Zhou, Ajay M. Vaghasia, Anne Hamacher‐Brady, Nathan Ryan Brady, Im‐Hong Sun, Rulin Wang, Avi Z. Rosenberg et al. · 2021 · Cell Reports
28. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor
    Dehong Yan, Adeleye Oluwatosin Adeshakin, Meichen Xu, Lukman Olalekan Afolabi, Guizhong Zhang, Youhai H. Chen, Xiaochun Wan · 2019 · Frontiers in Immunology
29. Reactive Oxygen Species and Antitumor Immunity—From Surveillance to Evasion
    Andromachi Kotsafti, Marco Scarpa, Ignazio Castagliuolo, Melania Scarpa · 2020 · Cancers
30. Anti-SIRPα antibodies as a potential new tool for cancer immunotherapy
    Tadahiko Yanagita, Yoji Murata, Daisuke Tanaka, Sei‐ichiro Motegi, Eri Arai, Edwin Widyanto Daniwijaya, Daisuke Hazama, Ken Washio, Yasuyuki Saito, Takenori Kotani et al. · 2017 · JCI Insight
31. Mechanisms underlying immunosuppression by regulatory cells
    Oliver Goldmann, Obiageli Vivian Nwofor, Qian Chen, Eva Medina · 2024 · Frontiers in Immunology
32. Neutrophil heterogeneity: Bona fide subsets or polarization states?
    Justin Deniset, Paul Kubes · 2018 · Journal of Leukocyte Biology
33. Targeting T Cell Metabolism for Improvement of Cancer Immunotherapy
    Thibault Le Bourgeois, Laura Strauss, Halil‐Ibrahim Aksoylar, Saeed Daneshmandi, Pankaj Seth, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2018 · Frontiers in Oncology
34. Monocytes Differentiate to Immune Suppressive Precursors of Metastasis-Associated Macrophages in Mouse Models of Metastatic Breast Cancer
    Takanori Kitamura, Dahlia Doughty-Shenton, Luca Cassetta, Stamatina Fragkogianni, Demi Brownlie, Yu Kato, Neil O. Carragher, Jeffrey W. Pollard · 2018 · Frontiers in Immunology
35. The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment
    Laura Agresta, Kasper H. N. Hoebe, Edith M. Janssen · 2018 · Frontiers in Immunology
36. Activation of immunosuppressive network in the aging process
    Antero Salminen · 2019 · Ageing Research Reviews
37. Single‐Cell Transcriptome Profiling Reveals Multicellular Ecosystem of Nucleus Pulposus during Degeneration Progression
    Ji Tu, Wentian Li, Sidong Yang, Pengyi Yang, Yan Qi, Shenyu Wang, Kaitao Lai, Xupeng Bai, Cenhao Wu, Wenyuan Ding et al. · 2021 · Advanced Science
38. Mouse versus Human Neutrophils in Cancer: A Major Knowledge Gap
    Evgeniy B. Eruslanov, Sunil Kumar Singhal, Steven Μ. Albelda · 2017 · Trends in cancer
39. Epidemiology and biology of relapse after stem cell transplantation
    Mary M. Horowitz, Hans Wilhelm Schreiber, Alex Elder, Olaf T Heidenreich, Josef H. Vormoor, Cristina Toffalori, Luca Vago, Nicolaus Martin Kröger · 2018 · Bone Marrow Transplantation
40. Obesity, Inflammation, and Prostate Cancer
    Kazutoshi Fujita, Takuji Hayashi, Makoto Matsushita, Motohide Uemura, Norio Nonomura · 2019 · Journal of Clinical Medicine
41. Cysteine Cathepsins in Tumor-Associated Immune Cells
    Tanja Jakoš, Anja Hafner Pišlar, Anahid Jewett, Janko Kos · 2019 · Frontiers in Immunology
42. Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
    Suguru Kadomoto, Kouji Izumi, Atsushi Mizokami · 2021 · International Journal of Molecular Sciences
43. The role of innate immune cells in the tumor microenvironment and research progress in anti-tumor therapy
    Chenglin Lu, Ying Liu, Nasra Mohamoud Ali, Bin Zhang, Xiaonan Cui · 2023 · Frontiers in Immunology
44. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy
    Bruce R. Blazar, Kelli P. A. MacDonald, Geoffrey R. Hill · 2018 · Blood
45. CD14 ⁺ CD15 ⁻ HLA-DR ⁻ myeloid-derived suppressor cells impair antimicrobial responses in patients with acute-on-chronic liver failure
    Bernsmeier, Christine, Triantafyllou, Evangelos, Brenig, Robert, Lebosse, Fanny J, Singanayagam, Arjuna, Patel, Vishal C, Pop, Oltin T, Khamri, Wafa, Nathwani, Rooshi, Tidswell, Robert et al. · 2018 · Gut
46. Immunogenomic identification and characterization of granulocytic myeloid-derived suppressor cells in multiple myeloma
    Cristina Pérez, Cirino Botta, Aintzane Zabaleta, Noemí Puig, María‐Teresa Cedena, Ibai Goicoechea, Daniel Alameda, Edurne San José‐Eneriz, Juana Merino, Paula Rodríguez‐Otero et al. · 2020 · Blood
47. Targeting Myeloid-Derived Suppressor Cell, a Promising Strategy to Overcome Resistance to Immune Checkpoint Inhibitors
    Aohan Hou, Kaiyu Hou, Qiubo Huang, Yujie Lei, Wan-Ling Chen · 2020 · Frontiers in Immunology
48. Chemotherapeutic agent-mediated elimination of myeloid-derived suppressor cells
    Zibing Wang, Brian G. Till, Quanli Gao · 2017 · OncoImmunology
49. Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
    Anca Dorhoi, Nelita du Plessis · 2018 · Frontiers in Immunology
50. Mature neutrophils suppress T cell immunity in ovarian cancer microenvironment
    Kelly L. Singel, Tiffany Rose Emmons, Anm Nazmul H. Khan, Paul C. Mayor, Shichen Shen, Jerry Thwin Wong, Kayla Morrell, Kevin Hasegawa Eng, Jaron Mark, Richard B. Bankert et al. · 2019 · JCI Insight
51. IL-6 and IL-8 Are Linked With Myeloid-Derived Suppressor Cell Accumulation and Correlate With Poor Clinical Outcomes in Melanoma Patients
    Richard P. Tobin, Kimberly Rae Jordan, Puja Kapoor, Eric Spongberg, Dana M. Davis, Victoria M. Vorwald, Kasey L. Couts, Dexiang Gao, Derek E. Smith, Jessica S.W. Borgers et al. · 2019 · Frontiers in Oncology
52. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8–CXCR2 Axis
    Ryotaro Ogawa, Takamasa S. Yamamoto, Hideyo Hirai, Keita Hanada, Yoshiyuki Kiyasu, Gen Nishikawa, Rei Mizuno, Susumu Inamoto, Yoshiro Itatani, Yoshiharu Sakai et al. · 2019 · Clinical Cancer Research
53. Targeting myeloid chemotaxis to reverse prostate cancer therapy resistance
    Christina W. Guo, Adam Sharp, Bora Gürel, Mateus Crespo, Ines Figueiredo, Suneil Jain, Ursula Maria Vogl, Jan Rekowski, Mahtab Rouhifard, Lewis Gallagher et al. · 2023 · Nature
54. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
    Donatella Aldinucci, Naike Casagrande · 2018 · International Journal of Molecular Sciences
55. Hypoxia Pathway Proteins As Central Mediators of Metabolism in the Tumor Cells and Their Microenvironment
    Sundary Sormendi, Ben Wielockx · 2018 · Frontiers in Immunology
56. Multidimensional imaging provides evidence for down-regulation of T cell effector function by MDSC in human cancer tissue
    Yu Si, Simon F. Merz, Philipp Jansen, Bao-Xiao Wang, Kirsten Bruderek, Petra Altenhoff, Stefan Mattheis, Stephan Lang, Matthias Gunzer, Joachim Klode et al. · 2019 · Science Immunology
57. Chemical functionality of multidomain peptide hydrogels governs early host immune response
    Tania L. Lopez‐Silva, David G. Leach, Alon R. Azares, I-Che Li, Darren G. Woodside, Jeffrey D. Hartgerink · 2019 · Biomaterials
58. Redefining macrophage and neutrophil biology in the metastatic cascade
    Esra Güç, Jeffrey W. Pollard · 2021 · Immunity
59. Neutrophil Heterogeneity as Therapeutic Opportunity in Immune-Mediated Disease
    Ricardo Grieshaber‐Bouyer, Peter Andrija Nigrovic · 2019 · Frontiers in Immunology
60. Redox control of cancer cell destruction
    Csaba Hegedűs, Katalin Éva Kovács, Zsuzsanna Polgár, Zsolt Regdon, Éva Szabó, Agnieszka Robaszkiewicz, Henry Jay Forman, Anna Martner, László Virág · 2018 · Redox Biology
61. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy
    Shweta Joshi, Andrew B. Sharabi · 2022 · Pharmacology & Therapeutics
62. Tumor-induced erythroid precursor-differentiated myeloid cells mediate immunosuppression and curtail anti-PD-1/PD-L1 treatment efficacy
    Haixia Long, Qingzhu Jia, Liuyang Wang, Wen‐Feng Fang, Zhongyu Wang, Tao Jiang, Fei Zhou, Jin Zheng, Jiani Huang, Li Zhou et al. · 2022 · Cancer Cell
63. LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma
    Tingting Cai, Shubiao Ye, Yi-Na Liu, Jia He, Qiu-Yan Chen, Hai‐Qiang Mai, Chuan-xia Zhang, Jun Cui, Xiao-Shi Zhang, Pierre Busson et al. · 2017 · PLoS Pathogens
64. How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions
    Annika M. Bruger, Anca Dorhoi, Güneş Esendağlı, Katarzyna Barczyk‐Kahlert, Pierre van der Bruggen, Marie Lipoldová, Tomáš Perečko, Juan Francisco Santibanez, Margarida Saraiva, Jo A. Van Ginderachter et al. · 2018 · Cancer Immunology Immunotherapy
65. The diverse roles of neutrophils from protection to pathogenesis
    Rana Herro, H. Leighton Grimes · 2024 · Nature Immunology
66. Emerging strategies in targeting tumor-resident myeloid cells for cancer immunotherapy
    Yi Wang, Kai Conrad Cecil Johnson, Margaret Elena Gatti-Mays, Zihai Li · 2022 · Journal of Hematology & Oncology
67. The current state and future of T-cell exhaustion research
    Edward M. Jenkins, Toby Whitehead, Martin Fellermeyer, Simon J. Davis, Sumana Sharma · 2023 · Oxford Open Immunology
68. Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling
    Viktor Fleming, Xiaoying Hu, Céline Weller, Rebekka Weber, Christopher Groth, Zeno Riester, Laura Hüser, Qian Sun, Vasyl S. Nagibin, Carsten J. Kirschning et al. · 2019 · Cancer Research
69. Prognostic role of pretreatment circulating MDSCs in patients with solid malignancies: A meta-analysis of 40 studies
    Peng-Fei Wang, Siying Song, Tingjian Wang, Wenjun Ji, Shouwei Li, Ning Liu, Changxiang Yan · 2018 · OncoImmunology
70. Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy
    Hans Raskov, Adile Orhan, Shruti Gaggar, Ismail Gögenür · 2022 · Oncogenesis
71. Strategies of neutrophil diversification
    Miguel Palomino‐Segura, Jon Sicilia, Iván Ballesteros, Andrés Hidalgo · 2023 · Nature Immunology
72. TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti–PD-1 Therapy in Melanoma
    Alisha Holtzhausen, William P. Harris, Eric Ubil, Debra M. Hunter, Jichen Zhao, Yuewei Zhang, Dehui� Zhang, Qingyang Liu, Xiaodong Wang, Douglas K. Graham et al. · 2019 · Cancer Immunology Research
73. Targeting advanced prostate cancer with STEAP1 chimeric antigen receptor T cell and tumor-localized IL-12 immunotherapy
    Vipul Bhatia, Nikhil V. Kamat, Tiffany E. Pariva, Liting Wu, Annabelle Tsao, Koichi Sasaki, Huiyun Sun, Gerardo Javier, W. Sam Nutt, Ilsa M. Coleman et al. · 2023 · Nature Communications
74. Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer
    Laura Chambers, Emily Esakov Rhoades, Rashmi Bharti, Chad Braley, Surabhi Tewari, Lexie Trestan, Zahraa Alali, Defne Bayık, Justin Durla Lathia, Naseer Sangwan et al. · 2022 · Cancer Research
75. Distinct myeloid-derived suppressor cell populations in human glioblastoma
    Christina Jackson, Christopher Cherry, Sadhana Bom, Arbor G. Dykema, Rulin Wang, Elizabeth A. Thompson, Ming Zhang, Runzhe Li, Zhicheng Ji, Wenpin Hou et al. · 2025 · Science
76. Targeting myeloid cells in the tumor sustaining microenvironment
    Jonathan Schupp, Franziska K. Krebs, Niklas Zimmer, Emily R. Trzeciak, Detlef Schuppan, Andrea Tuettenberg · 2017 · Cellular Immunology
77. Interleukin-6 Trans-Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells via Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer
    Mengmeng Jiang, Jieying Chen, Wenwen Zhang, Rui Zhang, Yingnan Ye, Pengpeng Liu, Wenwen Yu, Feng Wei, Xiubao Ren, Jinpu Yu · 2017 · Frontiers in Immunology
78. Inflammation: A key process in skin tumorigenesis (Review)
    Monica Teodora Neagu, Carolina Constantin, Constantin Căruntu, Carmen Dumitru, Mihaela Surcel, Sabina Zurac · 2018 · Oncology Letters
79. A biologic scaffold–associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy
    Wolf, Matthew T., Ganguly, Sudipto, Wang, Tony L., Anderson, Christopher W., Sadtler, Kaitlyn, Narain, Radhika, Cherry, Christopher, Parrillo, Alexis J., Park, Benjamin V., Wang, Guannan et al. · 2019 · Science Translational Medicine
80. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma
    Rebekka Weber, Zeno Riester, Laura Hüser, Carsten Sticht, Alina Siebenmorgen, Christopher Groth, Xiaoying Hu, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky · 2020 · Journal for ImmunoTherapy of Cancer
81. Blocking IL1 Beta Promotes Tumor Regression and Remodeling of the Myeloid Compartment in a Renal Cell Carcinoma Model: Multidimensional Analyses
    David Henry Aggen, Casey R. Ager, Aleksandar Obradović, Nivedita Chowdhury, Ali Ghasemzadeh, Wendy Mao, Matthew G. Chaimowitz, Zoila Areli Lopez Bujanda, Catherine S. Spina, Jessica E. Hawley et al. · 2020 · Clinical Cancer Research
82. Regulation of ROS in myeloid-derived suppressor cells through targeting fatty acid transport protein 2 enhanced anti-PD-L1 tumor immunotherapy
    Adeleye Oluwatosin Adeshakin, Wan Liu, Funmilayo Oladunni Adeshakin, Lukman Olalekan Afolabi, Mengqi Zhang, Guizhong Zhang, Lulu Wang, Zhihuan Li, Lilong Lin, Qin Cao et al. · 2021 · Cellular Immunology
83. Nano-enhanced immunotherapy: Targeting the immunosuppressive tumor microenvironment
    Yuzhi Jin, Yangyue Huang, Hui Ren, Huanhuan Huang, Chunyu Lai, Wenjun Wang, Zhou Tong, Hangyu Zhang, Wei Wu, Chuan Liu et al. · 2024 · Biomaterials
84. 161533 TriKE stimulates NK-cell function to overcome myeloid-derived suppressor cells in MDS
    Dhifaf Sarhan, Ludwig Brandt, Martin Felices, Karolin Guldevall, Todd R. Lenvik, Peter Hinderlie, Julie Curtsinger, Erica Dahl Warlick, Stephen R. Spellman, Bruce R. Blazar et al. · 2018 · Blood Advances
85. Myeloid-Derived Suppressor Cells: Major Figures that Shape the Immunosuppressive and Angiogenic Network in Cancer
    Vetsika, Eleni-Kyriaki, Koukos, Aristeidis, Kotsakis, Athanasios · 2019 · Cells
86. Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
    Graham Pawelec, Chris P. Verschoor, Suzanne Ostrand‐Rosenberg · 2019 · Frontiers in Immunology
87. Neutrophil Maturity in Cancer
    John B. G. Mackey, Seth B. Coffelt, Leo M. Carlin · 2019 · Frontiers in Immunology
88. CD47/SIRPα blocking peptide identification and synergistic effect with irradiation for cancer immunotherapy
    Hongfei Wang, Yixuan Sun, Xiuman Zhou, Chunxia Chen, Ling Jiao, Wanqiong Li, Shanshan Gou, Yanying Li, Jiangfeng Du, Guanyu Chen et al. · 2020 · Journal for ImmunoTherapy of Cancer
89. STAT3 in Tumor-Associated Myeloid Cells: Multitasking to Disrupt Immunity
    Yu‐Lin Su, Shuvomoy Banerjee, Seok Voon White, Marcin Kortylewski · 2018 · International Journal of Molecular Sciences
90. Recent advances on the crosstalk between neutrophils and B or T lymphocytes
    Sara Eleotério Costa, Dalila Bevilacqua, Marco Antonio Cassatella, Patrizia Scapini · 2018 · Immunology
91. Specialized immune responses in the peritoneal cavity and omentum
    Mingyong Liu, Aarón Silva-Sánchez, Troy D. Randall, Selene Meza‐Perez · 2020 · Journal of Leukocyte Biology
92. Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunity
    Benjamin Knier, Michael Hiltensperger, Christopher Sie, Lilian Aly, Gildas Lepennetier, Thomas Engleitner, Garima Garg, Andreas Muschaweckh, Meike Mitsdoerffer, Uwe Koedel et al. · 2018 · Nature Immunology
93. Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
    Mastio, Jérôme, Condamine, Thomas, Dominguez, George, Kossenkov, Andrew V., Donthireddy, Laxminarasimha, Veglia, Filippo, Lin, Cindy, Wang, Fang, Fu, Shuyu, Zhou, Jie et al. · 2019 · Journal of Experimental Medicine
94. Myeloid-derived suppressor cells in hematological malignancies: friends or foes
    Meng Lv, Ke Wang, Xiao‐Jun Huang · 2019 · Journal of Hematology & Oncology
95. Immune Responses in Bladder Cancer-Role of Immune Cell Populations, Prognostic Factors and Therapeutic Implications
    Magdalene Joseph, Deborah Enting · 2019 · Frontiers in Oncology
96. Myeloid cells in sepsis‐acquired immunodeficiency
    Fabienne Venet, Julie Demaret, Morgane Gossez, Guillaume Monneret · 2020 · Annals of the New York Academy of Sciences
97. Tumor-Associated Neutrophils and Macrophages—Heterogenous but Not Chaotic
    Ling Wu, Xiang H.-F. Zhang · 2020 · Frontiers in Immunology
98. Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
    Kevin M. Alicea-Torres, Emilio Sanseviero, Jun Gui, Jinyun Chen, Filippo Veglia, Qiujin Yu, Laxminarasimha Donthireddy, Andrew V. Kossenkov, Cindy Lin, Shuyu Fu et al. · 2021 · Nature Communications
99. Suppression of tumor-associated neutrophils by lorlatinib attenuates pancreatic cancer growth and improves treatment with immune checkpoint blockade
    Sebastian Rune Nielsen, Jan E. Strøbech, Edward R. Horton, René Jackstadt, Anu Laitala, Marina Crespo Bravo, Giorgia Maltese, Adina R. D. Jensen, Raphael Reuten, Maria Rafaeva et al. · 2021 · Nature Communications
100. The regulation of pre-metastatic niche formation by neutrophils
     Jadwiga Jabłońska, Stephan Lang, Ronit Vogt Sionov, Zvi Granot · 2017 · Oncotarget